MAPK7 and breast carcinoma: Accordingly, mammary graft studies, using human (MDA-MB-231) or murine (4T1) breast cancer cell lines that mirror the molecular subtype of TNBC, demonstrated that ERK5 knockdown suppressed metastasis [8–10].